• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chewy Announces Second Quarter 2023 Financial Results

    8/30/23 4:11:00 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $CHWY alert in real time by email

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the second quarter of fiscal year 2023 ended July 30, 2023, and posted a letter to its shareholders on its investor relations website at https://investor.chewy.com.

    Fiscal Q2 2023 Highlights:

    • Net sales of $2.78 billion improved 14.3 percent year over year
    • Gross margin of 28.3 percent increased 20 basis points year over year
    • Net income of $18.9 million, including share-based compensation expense and related taxes of $68.3 million
    • Net margin of 0.7 percent decreased 20 basis points year over year
    • Basic and diluted earnings per share of $0.04, a decrease of $0.01 year over year
    • Adjusted EBITDA(1) of $86.9 million, an increase of $3.8 million year over year
    • Adjusted EBITDA margin(1) of 3.1 percent decreased 30 basis points year over year
    • Adjusted net income(1) of $63.3 million, an increase of $1.2 million year over year
    • Adjusted basic and diluted earnings per share(1) of $0.15 remained flat year over year

    "We delivered solid results in Q2 across both topline and profitability, with 14% growth exceeding guidance," said Sumit Singh, Chief Executive Officer of Chewy. "Chewy once again gained share as our customers recognize the power of our personalized Autoship service, best-in-class healthcare experience, and overall value proposition as key differentiators, resulting in robust ordering behavior, which in turn is driving our strong performance."

    Management will host a conference call and webcast to discuss Chewy's financial results today at 5:00 pm ET.

    Chewy Fiscal Second Quarter 2023 Financial Results Conference Call

    When: Wednesday, August 30, 2023

    Time: 5:00 pm ET

    Conference ID: 225902

    Live Call: 1-833-470-1428 (US Toll-Free), 1-404-975-4839 (US Local), 1-404-975-4839 (International)

    Replay: 1-866-813-9403 (US Toll-Free), 1-929-458-6194 (US Local), 1-929-458-6194 (International)

    Replay Access Code: 979063

    (The replay will be available approximately two hours after the completion of the live call until 11:59 pm PT on September 6, 2023)

    Webcast: https://investor.chewy.com

    (1)

    Adjusted EBITDA, adjusted EBITDA margin, adjusted net income, and adjusted basic and diluted earnings per share are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

    About Chewy

    Our mission is to be the most trusted and convenient destination for pet parents and partners everywhere. We believe that we are the preeminent online source for pet products, supplies, and prescriptions as a result of our broad selection of high-quality products and services, which we offer at competitive prices and deliver with an exceptional level of care and a personal touch to build brand loyalty and drive repeat purchasing. We seek to continually develop innovative ways for our customers to engage with us, as our website and mobile app allow our pet parents to manage their pets' health, wellness, and merchandise needs, while enabling them to conveniently shop for our products. We partner with approximately 3,500 of the best and most trusted brands in the pet industry offering approximately 110,000 products and services offerings, to bring what we believe is a high-bar, customer-centric experience to our customers.

    Forward-Looking Statements

    This communication contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this communication, including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements.

    In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intend," "may," "plan," "potential," "predict," "project," "seek," "should," "target," "will" or "would" or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning our ability to: sustain our recent growth rates and successfully manage challenges to our future growth, including introducing new products or services, improving existing products and services, and expanding into new offerings; successfully manage risks related to the macroeconomic environment, including any adverse impacts on our business operations, financial performance, supply chain, workforce, facilities, customer services and operations; acquire and retain new customers in a cost-effective manner and increase our net sales, improve margins and maintain profitability; manage our growth effectively; maintain positive perceptions of our company and preserve, grow, and leverage the value of our reputation and our brand; limit operating losses as we continue to expand our business; forecast net sales and appropriately plan our expenses in the future; estimate the size of our addressable market; strengthen our current supplier relationships, retain key suppliers, and source additional suppliers; negotiate acceptable pricing and other terms with third-party service providers, suppliers and outsourcing partners and maintain our relationships with such parties; mitigate changes in, or disruptions to, our shipping arrangements and operations; optimize, operate and manage the expansion of the capacity of our fulfillment centers; provide our customers with a cost-effective platform that is able to respond and adapt to rapid changes in technology; limit our losses related to online payment methods; maintain and scale our technology, including the reliability of our website, mobile applications, and network infrastructure; maintain adequate cybersecurity with respect to our systems and ensure that our third-party service providers do the same with respect to their systems; maintain consumer confidence in the safety, quality and health of our products; limit risks associated with our suppliers and our outsourcing partners; comply with existing or future laws and regulations in a cost-efficient manner; compete with other retailers and service providers; utilize tax attributes, net operating loss and tax credit carryforwards, and limit fluctuations in our tax obligations and effective tax rate; adequately protect our intellectual property rights; successfully defend ourselves against any allegations or claims that we may be subject to; attract, develop, motivate and retain highly-qualified and skilled employees; predict and respond to economic conditions, industry trends, and market conditions, and their impact on the pet products market; reduce merchandise returns or refunds; respond to severe weather and limit disruption to normal business operations; manage new acquisitions, investments or alliances, and integrate them into our existing business; successfully compete in the pet insurance market; manage challenges presented by international markets; successfully compete in the pet products and services health and retail industry, especially in the e-commerce sector; raise capital as needed; and maintain effective internal control over financial reporting and disclosure controls and procedures.

    You should not rely on forward-looking statements as predictions of future events, and you should understand that these statements are not guarantees of performance or results, and our actual results could differ materially from those expressed in the forward-looking statements due to a variety of factors. We have based the forward-looking statements contained in this communication primarily on our current assumptions, expectations, and projections about future events and trends that we believe may affect our business, financial condition, and results of operations. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled "Risk Factors" included under Part I, Item 1A of our Annual Report on Form 10-K and in our other filings with the Securities and Exchange Commission and elsewhere in this communication. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this communication. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this communication. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. The forward-looking statements made in this communication relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this communication to reflect events or circumstances after the date of this communication or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

    Non-GAAP Financial Measures

    Adjusted EBITDA and Adjusted EBITDA Margin

    To provide investors with additional information regarding our financial results, we have disclosed in this earnings release adjusted EBITDA, a non-GAAP financial measure that we calculate as net income (loss) excluding depreciation and amortization; share-based compensation expense and related taxes; income tax provision; interest income (expense), net; transaction related costs; changes in the fair value of equity warrants; exit costs; and litigation matters and other items that we do not consider representative of our underlying operations. We have provided a reconciliation below of adjusted EBITDA to net income (loss), the most directly comparable GAAP financial measure.

    We have included adjusted EBITDA and adjusted EBITDA margin in this earnings release because each is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted EBITDA and adjusted EBITDA margin facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and certain variable charges. Accordingly, we believe that adjusted EBITDA and adjusted EBITDA margin provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.

    We believe it is useful to exclude non-cash charges, such as depreciation and amortization and share-based compensation expense from our adjusted EBITDA because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude income tax provision; interest income (expense), net; transaction related costs; changes in the fair value of equity warrants; exit costs; and litigation matters and other items which are not components of our core business operations. Adjusted EBITDA has limitations as a financial measure and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:

    • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future and adjusted EBITDA does not reflect capital expenditure requirements for such replacements or for new capital expenditures;
    • adjusted EBITDA does not reflect share-based compensation and related taxes. Share-based compensation has been, and will continue to be for the foreseeable future, a recurring expense in our business and an important part of our compensation strategy;
    • adjusted EBITDA does not reflect interest income (expense), net; or changes in, or cash requirements for, our working capital;
    • adjusted EBITDA does not reflect transaction related costs and other items which are either not representative of our underlying operations or are incremental costs that result from an actual or planned transaction and include changes in the fair value of equity warrants, exit costs, litigation matters, integration consulting fees, internal salaries and wages (to the extent the individuals are assigned full-time to integration and transformation activities) and certain costs related to integrating and converging IT systems; and
    • other companies, including companies in our industry, may calculate adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

    Because of these limitations, you should consider adjusted EBITDA and adjusted EBITDA margin alongside other financial performance measures, including various cash flow metrics, net income (loss), net margin, and our other GAAP results.

    The following table presents a reconciliation of net income to adjusted EBITDA, as well as the calculation of net margin and adjusted EBITDA margin, for each of the periods indicated.

    (in thousands, except percentages)

    13 Weeks Ended

     

    26 Weeks Ended

    Reconciliation of Net Income to Adjusted EBITDA

    July 30,

    2023

     

    July 31,

    2022

     

    July 30,

    2023

     

    July 31,

    2022

    Net income

    $

    18,946

     

     

    $

    22,345

     

     

    $

    41,127

     

     

    $

    40,817

     

    Add:

     

     

     

     

     

     

     

    Depreciation and amortization

     

    27,795

     

     

     

    20,338

     

     

     

    56,672

     

     

     

    37,678

     

    Share-based compensation expense and related taxes

     

    68,302

     

     

     

    39,739

     

     

     

    122,079

     

     

     

    66,933

     

    Interest income, net

     

    (8,928

    )

     

     

    (690

    )

     

     

    (16,944

    )

     

     

    (346

    )

    Change in fair value of equity warrants

     

    (29,192

    )

     

     

    —

     

     

     

    (20,258

    )

     

     

    —

     

    Income tax provision

     

    1,304

     

     

     

    —

     

     

     

    2,307

     

     

     

    —

     

    Exit costs

     

    5,260

     

     

     

    —

     

     

     

    7,617

     

     

     

    —

     

    Transaction related costs

     

    2,126

     

     

     

    237

     

     

     

    2,126

     

     

     

    1,395

     

    Other

     

    1,254

     

     

     

    1,086

     

     

     

    2,315

     

     

     

    (2,906

    )

    Adjusted EBITDA

    $

    86,867

     

     

    $

    83,055

     

     

    $

    197,041

     

     

    $

    143,571

     

    Net sales

    $

    2,777,769

     

     

    $

    2,431,011

     

     

    $

    5,562,444

     

     

    $

    4,859,338

     

    Net margin

     

    0.7

    %

     

     

    0.9

    %

     

     

    0.7

    %

     

     

    0.8

    %

    Adjusted EBITDA margin

     

    3.1

    %

     

     

    3.4

    %

     

     

    3.5

    %

     

     

    3.0

    %

    We define net margin as net income divided by net sales and adjusted EBITDA margin as adjusted EBITDA divided by net sales.

    Adjusted Net Income and Adjusted Basic and Diluted Earnings per Share

    To provide investors with additional information regarding our financial results, we have disclosed in this earnings release adjusted net income and adjusted basic and diluted earnings per share, which represent non-GAAP financial measures. We calculate adjusted net income as net income excluding share-based compensation expense and related taxes, changes in the fair value of equity warrants, and exit costs. We calculate adjusted basic and diluted earnings per share by dividing adjusted net income attributable to common stockholders by the weighted-average shares outstanding during the period. We have provided a reconciliation below of adjusted net income to net income, the most directly comparable GAAP financial measure.

    We have included adjusted net income and adjusted basic and diluted earnings per share in this earnings release because each is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted net income and adjusted basic and diluted earnings per share facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and certain variable gains and losses that do not represent a component of our core business operations. We believe it is useful to exclude non-cash share-based compensation expense because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude exit costs and the changes in the fair value of equity warrants, because exit costs and the variability of equity warrant gains and losses are not representative of our underlying operations. Accordingly, we believe that these measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.

    Adjusted net income and adjusted basic and diluted earnings per share have limitations as financial measures and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP. Other companies may calculate adjusted net income and adjusted basic and diluted earnings per share differently, which reduces their usefulness as comparative measures. Because of these limitations, you should consider adjusted net income and adjusted basic and diluted earnings alongside other financial performance measures, including various cash flow metrics, net income, basic and diluted earnings per share, and our other GAAP results.

    The following table presents a reconciliation of net income to adjusted net income, as well as the calculation of adjusted basic and diluted earnings per share, for each of the periods indicated.

    (in thousands, except per share data)

    13 Weeks Ended

     

    26 Weeks Ended

    Reconciliation of Net Income to Adjusted Net Income

    July 30,

    2023

     

    July 31,

    2022

     

    July 30,

    2023

     

    July 31,

    2022

    Net income

    $

    18,946

     

     

    $

    22,345

     

    $

    41,127

     

     

    $

    40,817

    Add:

     

     

     

     

     

     

     

    Share-based compensation expense and related taxes

     

    68,302

     

     

     

    39,739

     

     

     

    122,079

     

     

     

    66,933

     

    Change in fair value of equity warrants

     

    (29,192

    )

     

     

    —

     

     

     

    (20,258

    )

     

     

    —

     

    Exit costs

     

    5,260

     

     

     

    —

     

     

    $

    7,617

     

     

    $

    —

     

    Adjusted net income

    $

    63,316

     

     

    $

    62,084

     

     

    $

    150,565

     

     

    $

    107,750

     

    Weighted-average common shares used in computing adjusted earnings per share:

     

     

     

     

     

     

     

    Basic

     

    428,618

     

     

     

    421,690

     

     

     

    427,735

     

     

     

    421,048

     

    Effect of dilutive share-based awards

     

    2,958

     

     

     

    5,143

     

     

     

    3,289

     

     

     

    5,724

     

    Diluted

     

    431,576

     

     

     

    426,833

     

     

     

    431,024

     

     

     

    426,772

     

    Earnings per share attributable to common Class A and Class B stockholders

     

     

     

     

     

     

     

    Basic

    $

    0.04

     

     

    $

    0.05

     

     

    $

    0.10

     

     

    $

    0.10

     

    Diluted

    $

    0.04

     

     

    $

    0.05

     

     

    $

    0.10

     

     

    $

    0.10

     

    Adjusted basic

    $

    0.15

     

     

    $

    0.15

     

     

    $

    0.35

     

     

    $

    0.26

     

    Adjusted diluted

    $

    0.15

     

     

    $

    0.15

     

     

    $

    0.35

     

     

    $

    0.25

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230830033371/en/

    Get the next $CHWY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CHWY

    DatePrice TargetRatingAnalyst
    9/25/2025$48.00Neutral → Buy
    MoffettNathanson
    9/11/2025$47.00Neutral → Buy
    Seaport Research Partners
    9/11/2025$45.00Hold → Buy
    Deutsche Bank
    9/8/2025$50.00Neutral → Outperform
    Mizuho
    7/10/2025Mkt Outperform
    Citizens JMP
    6/9/2025$47.00Outperform → Neutral
    Mizuho
    6/5/2025$43.00Buy → Hold
    Jefferies
    3/24/2025Neutral
    Seaport Research Partners
    More analyst ratings

    $CHWY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chewy upgraded by MoffettNathanson with a new price target

    MoffettNathanson upgraded Chewy from Neutral to Buy and set a new price target of $48.00

    9/25/25 8:21:50 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Chewy from Neutral to Buy and set a new price target of $47.00

    9/11/25 8:35:47 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Chewy from Hold to Buy and set a new price target of $45.00

    9/11/25 8:34:30 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Billings William G. covered exercise/tax liability with 1,207 shares, decreasing direct ownership by 4% to 32,540 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    2/3/26 5:59:21 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chief Technology Officer Mehta Satish covered exercise/tax liability with 29,243 shares and sold $377,247 worth of shares (13,013 units at $28.99), decreasing direct ownership by 9% to 273,835 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    2/3/26 5:58:02 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chief Executive Officer Singh Sumit covered exercise/tax liability with 180,308 shares, decreasing direct ownership by 16% to 886,890 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    2/3/26 5:55:57 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Chewy Inc.

    SCHEDULE 13G/A - Chewy, Inc. (0001766502) (Subject)

    2/10/26 11:21:52 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 8-K filed by Chewy Inc.

    8-K - Chewy, Inc. (0001766502) (Filer)

    1/20/26 7:05:16 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Chewy Inc.

    SCHEDULE 13G - Chewy, Inc. (0001766502) (Subject)

    12/30/25 6:31:14 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Star James A bought $249,519 worth of shares (12,242 units at $20.38), increasing direct ownership by 9% to 141,790 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    12/18/23 4:09:39 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Star James A bought $300,992 worth of shares (15,353 units at $19.60), increasing direct ownership by 13% to 129,548 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    12/14/23 4:10:59 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chewy Announces Third Quarter 2025 Financial Results

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the third quarter of fiscal year 2025 ended November 2, 2025. Fiscal Q3 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.8 percent increased 50 basis points year over year Net income of $59.2 million, including share-based compensation expense and related taxes of $76.5 million Net margin of 1.9 percent increased 180 basis points year over year Basic earnings per share of $0.14, an increase of $0.13 year over year Diluted earnings per share of $0.14, an increase of $0.13 year over year Adjus

    12/10/25 7:05:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy Announces Fiscal Third Quarter 2025 Financial Results Conference Call

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal third quarter 2025 financial results before the market opens on Wednesday, December 10, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be acc

    11/19/25 7:30:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Covetrus Announces Agreement for Chewy to Acquire SmartEquine

    Transaction enables Covetrus to sharpen focus on core business of delivering technology-enabled solutions for veterinarians PORTLAND, Maine, Oct. 30, 2025 /PRNewswire/ -- Covetrus®, a global animal-health technology and services company, today announced that it has entered into a definitive agreement with Chewy, Inc. (NYSE:CHWY) for Chewy to acquire the SmartEquine® business. This transaction enables Covetrus to sharpen its focus on its core business of delivering technology-enabled solutions that help veterinarians improve practice performance and patient care. By concentrati

    10/30/25 11:48:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Leadership Updates

    Live Leadership Updates

    View All

    Chewy Set to Join S&P MidCap 400

    NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Chewy Inc. (NYSE: CHWY) will replace Stericycle Inc. (NASD: SRCL) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 6. S&P 500 constituent Waste Management Inc. (NYSE:WM) is acquiring Stericycle in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 6, 2024 S&P MidCap 400 Addition Chewy CHWY Consumer Discretionary November 6, 2024 S&P MidCap 400 Deletion Stericycle SRCL Industrial For more information about

    11/1/24 7:11:00 PM ET
    $CHWY
    $SPGI
    $SRCL
    Catalog/Specialty Distribution
    Consumer Discretionary
    Finance: Consumer Services
    Finance

    Chewy Appoints Mark Eamer as Chief Marketing Officer

    Seasoned Leader to Spearhead Continued Expansion of Chewy's Marketing and Customer Engagement Capabilities Chewy, Inc. ("Chewy") (NYSE:CHWY), a leading online destination for pet parents and partners, announced today the appointment of Mark Eamer as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210930005601/en/Chewy Appoints Mark Eamer as Chief Marketing Officer (Photo: Business Wire) As CMO, Mark will spearhead the continued expansion of Chewy's Marketing and Customer Engagement capabilities, with ownership of the company's marketing strategy, partnerships and analytics, including full funnel cus

    9/30/21 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    GameStop Announces Additional Board Refreshment to Accelerate Transformation

    Aligns with Ryan Cohen of RC Ventures on the Immediate Appointment of Three New Directors with Significant E-Commerce and Technology Experience Confirms the Board’s Commitment to Supporting GameStop’s Pursuit of Growth and Market Leadership GRAPEVINE, Texas, Jan. 11, 2021 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it has entered into an agreement with RC Ventures LLC (“RC Ventures”) that will advance the refreshment of the Company’s Board of Directors (the “Board”). RC Ventures, which is one of the Company’s largest stockholders, is managed by Ryan Cohen. The agreement provides for the immediate appointment of three new directors –

    1/11/21 7:30:00 AM ET
    $CHWY
    $GME
    Catalog/Specialty Distribution
    Consumer Discretionary
    Electronics Distribution

    $CHWY
    Financials

    Live finance-specific insights

    View All

    Chewy Announces Third Quarter 2025 Financial Results

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the third quarter of fiscal year 2025 ended November 2, 2025. Fiscal Q3 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.8 percent increased 50 basis points year over year Net income of $59.2 million, including share-based compensation expense and related taxes of $76.5 million Net margin of 1.9 percent increased 180 basis points year over year Basic earnings per share of $0.14, an increase of $0.13 year over year Diluted earnings per share of $0.14, an increase of $0.13 year over year Adjus

    12/10/25 7:05:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy Announces Fiscal Third Quarter 2025 Financial Results Conference Call

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal third quarter 2025 financial results before the market opens on Wednesday, December 10, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be acc

    11/19/25 7:30:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy Announces Second Quarter 2025 Financial Results

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the second quarter of fiscal year 2025 ended August 3, 2025. Fiscal Q2 2025 Highlights: Net sales of $3.10 billion increased 8.6 percent year over year Gross margin of 30.4 percent increased 90 basis points year over year Net income of $62.0 million, including share-based compensation expense and related taxes of $79.1 million Net margin of 2.0 percent decreased 850 basis points year over year(2) Basic earnings per share of $0.15, a decrease of $0.55 year over year(2) Diluted earnings per share of $0.14, a decrease of $0.54 year over ye

    9/10/25 7:05:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Chewy Inc.

    SC 13G/A - Chewy, Inc. (0001766502) (Subject)

    11/12/24 2:29:11 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Chewy Inc.

    SC 13G/A - Chewy, Inc. (0001766502) (Subject)

    11/6/24 4:39:56 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Chewy Inc.

    SC 13G/A - Chewy, Inc. (0001766502) (Subject)

    11/4/24 11:23:07 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary